Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Clinical trial NCT03260023 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03260023
Sponsor: Transgene
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HPV-Related Carcinoma HPV-Related Cervical Carcinoma HPV-Related Anal Squamous Cell Carcinoma HPV-Related Penile Squamous Cell Carcinoma HPV-Related Vulvar Squamous Cell Carcinoma

Start date: 2017-09-01
Primary completion: 2024-09-18
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.